Sekisui Chemical <4204>
It has been reported that Sharp is considering acquiring part of its Sakai factory. It is expected to be a production base for the next-generation solar cell 'Perovskite Solar Cell' aiming to commercialize in 2025, and it is reported that the Ministry of Economy, Trade and Industry is also planning to support it with subsidies and others. On the 25th, the stock price is likely to make a move aiming to break the 75-day moving average, while also being conscious of the 200-day line as a support line.
Santen Pharmaceutical <4536>
It was bought up to 1878.5 yen on August 30, and then showed a correction, but the 25-day line is being conscious as a support line. On the weekly chart, it continues the trend of using the 13-week line, which is generally upward, as a support line, and the buying interest for waiting for a dip is strong. The Parabolic SAR value is located around 1870 yen at the +1σ level of the Bollinger Bands, and the signal will turn positive if it catches around that level.